B/BE/20/BVW2 - Advice Biosafety Advisory Council

5 June 2020 - The Biosafety Advisory Council issues a positive advice (with conditions) for this deliberate release
Trial reference: 
A first-in human, Phase 1b/2, study to evaluate the safety, tolerability and immunogenicity of HPV viral vectored vaccines in women with low-grade HPV-related cervical lesions